Materials and Methods
Animals and Surgery. Merino ewes, 8-10 mo old, were used in all experiments . They were kept in metabolism cages and given lucerne chaff and water ad libitum .
The popliteal efferent lymph duct and afferent lymph duct draining the lower part of the right hind leg were cannulated, as described by Hall and Morris (10) . At the time of surgery, a cannula was placed in the jugular vein for taking blood samples .
Lymph Collection . Lymph was collected continuously in sterile polyethylene bottles that contained 1 ml of normal saline supplemented with 500 U of preservative-free heparin (Commonwealth Serum Laboratories, Melbourne, Australia), 500 IU of penicillin, and 500 ug of streptomycin (Flow Laboratories, Melbourne, Australia) . The lymph collection bottles were changed at regular intervals . The cell concentration in each collection was determined using a Coulter Counter fitted with a 100-wM aperature tube (model FN ; Coulter Electronics Ltd ., Dunstable, Bedfordshire, UK) . At least 3 d after surgery, when the changes in the lymph caused by surgery and anesthesia had subsided, lymph was collected for 8 h and the phenotype of cells in lymph and blood was determined . The popliteal lymph node was removed at the same time for preparation of cell suspensions and immunohistology.
mAbs. mAbs to sheep lymphocyte antigens were produced within the Department of Veterinary Preclinical Sciences, Melbourne University, (Melbourne, Australia) and were used as undiluted tissue culture supernatants .
mAbs were characterized by immunoprecipitation and molecular weight analysis and by immunohistology and tissue distribution . Table I summarizes the reactivities of the mAbs and gives the references describing their characterization .
Cell Suspensions. Cell suspensions of lymph nodes were prepared by gentle teasing of lymph nodes with forceps in PBS containing 1% BSA . Clumps were removed by filtering the suspension through cotton gauze, and the cells were washed three times in a solution of PBS/BSA . Peripheral blood was taken from the jugular vein in a solution of EDTA (6 .2 mg/ml blood ; Ajax Chemicals, Melbourne, Australia) and treated with ammonium chloride to lyse RBC . Ammonium chloride/Tris lysis buffer was prepared by mixing 9 vol of 0 .83% ammonium chloride with 1 vol of 0 .17 M Tris, and the pH of the Tris-NH4Cl solution was adjusted to 7 .2 before use . The lysis buffer was warmed to 37°C and 5 ml of buffer was used per 1 ml of blood . Erythrocytes usually lysed within 1-3 min . Blood lymphocytes obtained after ammonium chloride lysis were identified on the flow cytometer using 0°and 90°light scatter.
Immunoftuorescence and Flow Cytometry. For single-color immunofluorescent staining with mAbs, 10 6 cells were reacted with 50 pl of neat tissue culture supernatant for 30 min at 4°C, were washed three times in a solution of PBS/BSA, and were then reacted with FITC-sheep anti-mouse Ig (Silenus Laboratories, Melbourne, Australia) . FITC-donkey anti-sheep Ig (Silenus Laboratories) was used to enumerate cell surface Ig' (slg') lymphocytes . After staining, cells were fixed in a solution of 1% paraformaldehyde in PBS containing 0 .1% sodium azide.
Analysis of sheep lymphocytes by flow Cytometry was performed using a FAGS II (Becton Dickinson FAGS Systems, Sunnyvale, CA) . For one-color immunofluorescent analysis or forward angle light scatter analysis, 10 4 cells were analyzed per sample and dead cells were excluded on the basis of forward light scatter.
Immunoperoxidase Staining. Tissues were submersed in OCT embedding compound (LabTek, Naperville, IL), snap frozen in liquid nitrogen, and stored at -70°C . Frozen sections (3-5 1tm) were placed on xylene-cleaned slides, air dried for 1 h, and fixed in absolute alcohol for 10 min at 4°C . Sections were exposed to mAbs for 1 h, washed with PBS, and then reincubated for 1 h with peroxidase-conjugated rabbit anti-mouse Ig (Dako Immunoglobulins, Copenhagen, Denmark) . After washing, slides were developed in a solution of diaminobenzidene tetrahydrochloride (Sigma Chemical Co ., St . Louis, MO ; 0 .5 mg/ml in a 0 .25 M Tris, 0 .14 M NaCl, pH 7 .6) and H202 (0 .01%) . Sections were then lightly counterstained with hematoxylin .
Cytospots of efferent or afferent lymph lymphocytes were prepared using a cytocentrifuge (Shandon Southern Instruments Inc ., St . Sewickley, PA), as previously described (11) . Slides were stained by the immunoperoxidase method as described above for tissue sections .
Arithmetic means of the proportion of stained cells in each compartment were compared using the Mann-Whitney U test (12) . Comparisons of the percentages of each subpopulation between the compartments were made using the Mann-Whitney U test . Unless specified, there were no significant differences between compartments as P 4 0 .05 . Significantly different at P 4 0 .05 from other values in the same column . 4 Significantly different at P 4 0 .05 from the other values in the column with the same footnote . I I Significantly different at P 4 0 .05 from the other values in the column with the same footnote .
dividual sheep, and the cells were reacted with the panel ofmAbs (Table I ) and were analyzed using flow cytometry.
The distribution of lymphocyte subsets analyzed using flow cytometry is shown in Fig. 1 and Table II . CD5' lymphocytes were the major lymphocyte subpopulation in all compartments examined. The higher percentage of CD5' lymphocytes in afferent lymph was statistically different from the percentage of CD5' lymphocytes in blood, efferent lymph, or in the lymph node, and was associated with a much lower percentage of sIg' lymphocytes. Another difference in the distribution of CD5' lymphocytes was that nearly 25% of T cells in afferent lymph were SBU-T19' . This was in marked contrast to the much lower percentage of SBUT19' cells in the lymph node, the efferent lymph draining the node, or the blood supplying the node .
The SBUT19' lymphocyte subset in sheep is unique in that these cells are CD5' , but CD4-, CD8-, and sIg-. The cellular lineage of these cells was uncertain, a]- MHC antigen expression and cell size of afferent and efferent lymphocytes . Top profiles show efferent lymphocytes, and bottom profiles show afferent lymphocytes. Percentage staining was assessed by indirect immunofluorescence and flow cytometry . Cell outputs and fluorescent staining were determined from an 8-h collection of lymph collected at least 3 d after surgery, at a time when the lymph output was regarded as physiologically normal and free from RBC and granulocyte contamination . though they were originally described as T cells (14) based on the fact they are CD5+ and appear in the thymus during early ontogeny (17) . Recently, however, using a rabbit anti-human CD3 antisera, immunoprecipitation of CD3 molecules prepared from a lysate made from purified SBUT19' cells showed the presence of three CD3 bands migrating at 19 kD, 20 kD, and 24 kD. CD4 or CD8 antigens could not be precipated from the lysate. (Hein, W., M.-F. Beya, R. Kudo, C . Mackay, and S. McClure, manuscript in preparation) . The percentage of CD4' lymphocytes was much higher in the lymph node and in afferent and efferent lymph compared with blood although there was no significant difference in the distribution of CD4+ cells between the two lymph compartments and the lymph node . The percentage of CD8+ lymphocytes was higher in afferent and efferent lymph than in peripheral blood but there were no significant differences between the lymph node and the two lymph compartments .
A further lymphocyte subset that was CD5+ but negative for all other markers was present in peripheral blood (22%) and afferent lymph (11%) but could not be demonstrated in the lymph node or efferent lymph. The percentage of null cells (cells that did not express either CD5 of sIg) also varied between the compartments examined . For example, the percentage of null cells in afferent and efferent lymph was <8% compared with up to 25% null cells in blood.
Expression ofMHCAntigens on Cells in Different Lymphoid Compartments. Lymphocytes from afferent lymph, efferent lymph, the lymph node and blood were analyzed for expression of MHC class I and class II antigens by immunofluorescent staining and flow cytometry. mAbs used for analysis were reacted with cells under saturating antibody-binding conditions . The percentage of MHC class II' lymphocytes was the same in all compartments except the lymph node where the percentage ofMHC class II' lymphocytes was significantly higher than blood. A striking difference in the distribution of MHC class II' lymphocytes was found in afferent lymph compared with other compartments where nearly 30% of T cells were MHC class W .
All lymphocytes in blood, efferent and afferent lymph, and lymph nodes were MHC class I+ . However, Fig . 2 demonstrates that there was a much higher density of MHC class I antigens expressed on lymphocytes in afferent lymph than on lymphocytes in blood or efferent lymph . Forward angle light scatter (cell size) analysis revealed that afferent lymph lymphocytes were only slightly larger than lymphocytes from efferent lymph (Fig . 2) . Output of Lymphocyte Subpopulations from Afferent and Efferent Popliteal Lymph. Table  III shows the hourly output of lymphocytes from popliteal efferent and afferent lymph of an individual sheep . The hourly output of small lymphocytes from efferent lymph was 50 times greater than from afferent lymph . Only one afferent lymphatic was cannulated, however, the total input of small lymphocytes from afferent lymph does not exceed 5-10% of the output from efferent lymph (5) .
Clearly, the output of lymphocyte subpopulations from afferent lymph, no matter how enriched for a given lymphocyte subpopulation, cannot account for differences in the outputs of lymphocyte subsets observed in efferent lymph . This is apparent even for subpopulations in efferent lymph such as SBU T19 + cells where the hourly output was only -3-6 x 106 yet the total afferent hourly output was an estimated 106 . This was despite the fact that SBU T19+ cells were present in four times the concentration in afferent lymph than efferent lymph . Section of sheep popliteal lymph node showing the distribution of SBUT19' (x 100) . Stained cells were localized to the subcapsular sinus, trabeculae, and to the medulla, but were largely absent from B cell follicles and T cell domains.
Immunoperoxidase Staining of Cytocentrifuged Afferent Lymphatic Cells. The phenotype of macrophages in afferent lymph was examined using immunoperoxidase staining on cytospots. All macrophages showed strong expression of MHC class II antigens (Fig . 3) . CDl was expressed on virtually all macrophages, but not by lymphocytes (Fig . 3) . Many of the macrophages possessed long intensely stained "veils" and were taken to represent dendritic cells. CD4 was also expressed on -50% of macrophages.
Distribution of SBUT19' Cells in Lymph Nodes of Sheep. Fig. 4 shows a peripheral lymph node stained for SBUT19. SBUT19+ cells were prominent in the outer cortex close to the subcapsular sinus and were also associated with trabeculae and medullary sinuses. SBUT19' cells were usually scattered sparsely throughout the deep cortex and medulla and were absent from B cells follicles.
Discussion
The experiments described in this report are the first to examine simultaneously the distribution of lymphocyte subsets circulating in blood and in the afferent lymph and efferent lymph of a peripheral lymph node . Within these compartments, marked differences in the percentages of certain lymphocyte subsets were apparent, which suggests that certain lymphocyte subsets may leave the blood with differing efficiencies . Lymphocyte subpopulations also appear to be extracted from the blood at different rates by the lymph node as opposed to subcutaneous vascular endothelium.
The distribution of lymphocytes within different anatomical sites throughout the body depends upon both the delivery of cells to a tissue by the blood and the capacity of lymphocytes to cross specialized endothelium at those sites. Analysis of lymphocyte recirculation in sheep has demonstrated that there are at least three subpopulations of lymphocytes that recirculate by different pathways . Lymphocytes from intestinal lymph recirculate preferentially back into intestinal lymph, whereas lymphocytes from peripheral lymph nodes recirculate preferentially back into peripheral lymph node efferent lymph (6, 18, 19) . A third population of lymphocytes has been shown to recirculate preferentially to lymph draining sites of chronic inflammation (20) . The exit of circulating lymphocytes from blood may be controlled by specific molecular interactions between lymphocytes and endothelial cells (21) . Thus different lymphocyte-endothelial cell interactions may occur in various tissues enabling lymphocytes to migrate preferentially to peripheral lymph nodes, to gut, or to sites of inflammation (3, 21, 22) .
The differences in the distribution oflymphocyte subpopulations between the various lymphoid compartments reported in this paper may result from lymphocyte subsets bearing different migration-related cell surface molecules . Accordingly, endothelial cells would express complementary cell surface molecules that would differ from vascular bed to vascular bed either in the nature of the molecules expressed or in their number.
In this study, CD5+ lymphocytes were present in a much higher concentration in afferent lymph than in blood or efferent lymph. However, traffic endothelium in lymph nodes transmitted many more CD5 + cells than in subcutaneous vascular beds (see Table III ) although the delivery of lymphocytes to both vascular beds was estimated to be similar. It follows that the lymph node vascular bed as a whole is far more efficient at transmitting CD5' lymphocytes into efferent lymph than the subcutaneous vascular bed as a whole is in transmitting CD5+ lymphocytes into afferent lymph . The enrichment of CD5+ cells compared with B cells in afferent lymph as opposed to efferent lymph could be explained if subcutaneous vascular endothelium transmits CD5+ lymphocytes in preference to B lymphocytes, either by positively selecting for the former or negatively selecting for the latter. Differences in the migration of T lymphocyte subsets at lymph nodes and the skin and subcutaneous tissues could be explained by the expression ofdifferent cell migrationrelated cell surface molecules on each lymphocyte subset associated with quantitative differences in the expression ofcomplementary molecules on traffic endothelium . For example, if the complementary molecule to a migration-related cell surface molecule specific for SBU T19' lymphocytes was expressed in greater numbers on subcutaneous vascular endothelium than on endothelium in lymph nodes, SBU T19+ lymphocytes may bind to endothelium more efficiently in the subcutaneous tissues resulting in a higher extraction rate for SBU T19' cells from blood into afferent lymph than for blood into efferent lymph . If this notion is correct, the endothelium, not the lymphocyte, is the key factor in regulating the nonrandom exit of lymphocyte subsets from different vascular beds.
The higher concentration of T lymphocytes and their subpopulations in afferent lymph compared with blood could also be explained if T lymphocytes were dividing in the tissue spaces after they left the blood and before they appeared in afferent lymph . The modal transit time of T lymphocytes from blood to afferent lymph is ti 18-20 h and is the same as the transit time of T lymphocytes from blood through the lymph node into efferent lymph (23) . Such an explanation would require a high turnover of T lymphocytes in the tissue spaces for which there is no evidence . However, there is evidence that in a nonstimulated lymph node such as those examined in our study, < 2-3 of lymphocytes in efferent lymph are newly formed (4), so the higher concentration of CD4+ lymphocytes in efferent lymph compared with blood could not be due to the proliferation of CD4`lymphocytes in the lymph node.
The percentages of CD4' and CD8`lymphocytes in sheep blood were much lower than those reported for human blood. Typically, the CD4+ and CD8+ subsets represent 20-25% and 10-12% of sheep PBL, respectively (13) , although in this study the values for these subsets were even lower. Sheep blood also has a higher percentage of B cells than human blood, as well as 10-15 % SBUT19' cells. An analogous population in human blood to SBUT19 could be represented by the CD3+, CD5+, CD4 -, and CD8-subset that expresses the y chain of the T cell receptor (24) . Human and mouse lymphokine-activated killer effector cells, but not precursor cells, can show a similar phenotype to SBUT19 cells, although CD3`, CD4-, and CD8-T cells in human peripheral blood constitute only 3% of lymphocytes (25) .
The SBUT19 subset exhibited an interesting distribution in lymph nodes where they were located mainly in the subcapsular cortex and adjacent to trabeculae. Few SBUT19' cells were observed within conventional T cell or B cell domains. The high concentration of SBUT19+ lymphocytes in afferent lymph could partly account for their unusual distribution in the lymph node although it must be conceded that the majority of SBUT19`lymphocytes in lymph nodes at any one time will have entered the lymph node via lymph node vascular endothelium . Any consideration of the contribution to the output of SBUT19+ lymphocytes in efferent lymph by cells from afferent lymph should take into account that, as far as we are aware, afferent lymph lymphocytes have never actually been shown to migrate into efferent lymph.
The majority of lymphcytes in afferent lymph express greater amounts of MHC class I antigen than lymphocytes in efferent lymph or blood. We have no explanation for how this occurs . We also have no explanation for the large numbers of MHC class II+ T lymphocytes in afferent lymph although in both cases it seems likely that altered expression of MHC antigens occurs after lymphocytes have left the blood and before they have entered afferent lymph. There is no direct evidence to support this proposition nor is there any evidence to support the notion that such lymphocytes have migrated preferentially into afferent lymph because they bear MHC class II antigens . The observed expression of MHC antigens on lymphocytes in afferent lymph is all the more confusing in view of their anergy in graft-vs .-host reactions as reported by Scollay & Lafferty (7) . Studies on human afferent lymph have also shown a high percentage of T cells that express MHC class 11 antigens (26) . Other studies on afferent lymph cells in sheep have not demonstrated large numbers of MHC class IV cells, although increased levels of MHC class II expression were observed after antigenic stimulation . The same study reported complete de novo synthesis by efferent T cells from undetectable levels to nearly double the number of class II molecules found on B cells after immunological stimulation (27) .
10-20% of cells in afferent lymph are large macrophage-like cells. Their presence in afferent lymph raises the question of their origin and subsequent fate after entering the node since they are not seen in efferent lymph. The phenotypic analysis ofafferent lymph macrophages reported here supports the idea that at least a proportion ofthese cells are Langerhans' cells that have migrated from the skin. All afferent lymph dendritic cells were intensely MHC class II' and CDl + while -50% were CD4', similar to the phenotype of Langerhans' cells in human epidermis (28) . The CDl' veiled dendritic cells in afferent lymph may be Langerhans' cells that have left the epidermis, but the relationship of these cells to Langerhans' cells is difficult to define in sheep because they do not contain Birbeck granules although they do phagocytose immune complexes in vivo (29) .
Summary
The surface phenotypes (CD1, CD4, CD5, CD8, SBU T19, MHC class I, MHC class II, and sIg) of cells in blood, lymph nodes, and lymph were determined to examine simultaneously the distribution oflymphocyte subsets circulating in blood, afferent lymph, and efferent lymph ofa peripheral lymph node. Marked differences in the percentage of certain lymphocyte subsets were apparent within the compartments examined, suggesting that lymphocyte subsets leave the blood with differing efficiencies. Lymphocyte subsets also appeared to be extracted from the blood at different rates by lymph node as opposed to subcutaneous vascular endothelium. Endothelial cells in different vascular beds may express different numbers ofmolecules complementary to a set of migration-related cell surface molecules specific for each lymphocyte subset . Accordingly, the vascular endothelium would be the key factor in regulating nonrandom cell migration .
